Filing metadata

Accession number
0001213900-23-049014
Form type
Form 4
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Jun 14, 2023
Reporting period
Jun 12, 2023
Description
Insider transaction

Explore SEC Filings Hub